Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial.
Lheureux S, Krieger S, Weber B, Pautier P, Fabbro M, Selle F, Bourgeois H, Petit T, Lortholary A, Plantade A, Briand M, Leconte A, Richard N, Vilquin P, Clarisse B, Blanc-Fournier C, Joly F. Lheureux S, et al. Among authors: pautier p. Int J Gynecol Cancer. 2012 Nov;22(9):1483-8. doi: 10.1097/IGC.0b013e31826d1438. Int J Gynecol Cancer. 2012. PMID: 23027040 Clinical Trial.
Results of conservative treatment in epithelial ovarian carcinoma.
Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C, de Crevosier R, Haie-Meder C, Duvillard P, Castaigne D. Morice P, et al. Among authors: pautier p. Cancer. 2001 Nov 1;92(9):2412-8. doi: 10.1002/1097-0142(20011101)92:9<2412::aid-cncr1590>3.0.co;2-7. Cancer. 2001. PMID: 11745298
Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
Pautier P, Genestie C, Fizazi K, Morice P, Mottet C, Haie-Meder C, Le Cesne A, Lhommé C. Pautier P, et al. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):749-54. doi: 10.1046/j.1525-1438.2002.01144.x. Int J Gynecol Cancer. 2002. PMID: 12445254
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol.
Lotz JP, Pautier P, Selle F, Viens P, Fabbro M, Lokiec F, Viret F, Gligorov J, Gosse B, Provent S, Ribrag V, Micléa JM, Dosquet C, Goetschel A, Cailliot C, Lefèvre G, Genève J, Lhommé C; Groupe d' Intensification des traitements des Tumeurs Ovariennes (ITOV Group). Lotz JP, et al. Among authors: pautier p. Bone Marrow Transplant. 2006 Apr;37(7):669-75. doi: 10.1038/sj.bmt.1705310. Bone Marrow Transplant. 2006. PMID: 16501591 Clinical Trial.
[Standards, Options: Recommendations for the management of patients with epithelial ovarian cancer. Medical front-line treatment (summary report, update 2008)].
Fédération nationale des centres de lutte contre le cancer (FNCLCC). Fédération nationale des centres de lutte contre le cancer (FNCLCC). Gynecol Obstet Fertil. 2008 Jun;36(6):684-700. doi: 10.1016/j.gyobfe.2008.04.009. Epub 2008 Jun 9. Gynecol Obstet Fertil. 2008. PMID: 18539509 Review. French.
Primary psammocarcinoma of the ovary or peritoneum.
Poujade O, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P. Poujade O, et al. Among authors: pautier p. Int J Gynecol Cancer. 2009 Jul;19(5):844-6. doi: 10.1111/IGC.0b013e3181a69a26. Int J Gynecol Cancer. 2009. PMID: 19574771
360 results